M&T Bank
CTKB icon

M&T Bank’s Cytek Biosciences CTKB Stock Holding History

M&T Bank’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$78K Buy
+13,137
New +$62.3K ﹤0.01% 1722
2026
Q2 		– Sell
-10,308
Closed -$45K – 1793
2026
Q1 		$45K Buy
10,308
+51
+0.5% +$241 ﹤0.01% 1675
2025
Q4 		$51.8K Buy
+10,257
New +$47.6K ﹤0.01% 1651

Other funds holding CTKB

Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

M&T Bank's CTKB Position: Q3 2026 in Review

M&T Bank opened a new position in Cytek Biosciences (CTKB) in Q3 2026: 13,137 shares worth $78K. The stake represents ﹤0.01% of the portfolio and ranks #1722 among its holdings. This is a return to the name: M&T Bank previously reported a position in CTKB as recently as Q1 2026.

M&T Bank first reported a position in CTKB in Q4 2025 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • M&T Bank held 13,137 shares of Cytek Biosciences worth $78K as of Q3 2026.
  • Cytek Biosciences was a new M&T Bank position in Q3 2026.
  • Cytek Biosciences made up ﹤0.01% of M&T Bank's portfolio in Q3 2026, its #1722 holding.
  • M&T Bank first reported a position in Cytek Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 68 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on M&T Bank's 13F filing for Q3 2026, filed 10 Nov 2026.